How different are the costs and consequences of delayed versus immediate HIV treatment?

dc.contributor.authorWelte A.
dc.contributor.authorHargrove J.
dc.contributor.authorDelva W.
dc.contributor.authorWilliams B.
dc.contributor.authorStander T.
dc.date.accessioned2011-10-13T16:58:51Z
dc.date.available2011-10-13T16:58:51Z
dc.date.issued2011
dc.description.abstract[No abstract available]
dc.description.versionArticle
dc.identifier.citationSouth African Medical Journal
dc.identifier.citation101
dc.identifier.citation6
dc.identifier.citationhttp://www.scopus.com/inward/record.url?eid=2-s2.0-79958056702&partnerID=40&md5=2b2c153df2f5399c89b6bf31e6650399
dc.identifier.issn2569574
dc.identifier.urihttp://hdl.handle.net/10019.1/16883
dc.subjectantiretrovirus agent
dc.subjectarticle
dc.subjectcost benefit analysis
dc.subjectearly intervention
dc.subjectendemic disease
dc.subjecthealth care
dc.subjecthealth care cost
dc.subjecthealth care delivery
dc.subjecthealth care policy
dc.subjecthighly active antiretroviral therapy
dc.subjecthuman
dc.subjectHuman immunodeficiency virus infection
dc.subjectincidence
dc.subjectlife expectancy
dc.subjectSouth Africa
dc.subjecttherapy delay
dc.titleHow different are the costs and consequences of delayed versus immediate HIV treatment?
dc.typeArticle
Files